Hematologic markers predict nasopharyngeal cancer survival

September 22, 2015
Hematologic markers predict nasopharyngeal cancer survival

(HealthDay)—Pretreatment neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be predictors for survival in nasopharyngeal carcinoma, according to a study published online Sept. 11 in Head & Neck.

Wei Sun, M.D., from the Huazhong University of Science and Technology in Wuhan, China, and colleagues evaluated the prognostic significance of various hematologic parameters in 251 patients with .

The researchers found that NLR ≥2.7 (hazard ratio, 2.01; P = 0.005) and PLR ≥167.2 (hazard ratio, 2.12; P = 0.001) were significantly associated with shorter progression-free survival, while PLR ≥163.4 was correlated with poor overall survival (hazard ratio, 2.64; P = 0.011).

"Pretreatment NLR and PLR can be independent prognostic factors for patients with NPC," the authors write.

Explore further: Enoxaparin prevents VTEs in advanced pancreatic cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Enoxaparin prevents VTEs in advanced pancreatic cancer

May 20, 2015

(HealthDay)—For patients with advanced pancreatic cancer (APC), enoxaparin is effective for prevention and treatment of venous thromboembolic events (VTEs), according to a study published online May 18 in the Journal of ...

ERCC1 SNP can identify good prognosis in nasopharyngeal CA

August 27, 2015

(HealthDay)—Excision repair cross-complementing group 1 (ERCC1) genotype for the single nucleotide polymorphism (SNP) cytosine-to-thymine substitution at codon 118 (C118T) interacts with post-radiotherapy plasma Epstein-Barr ...

Treatments show promise in metastatic melanoma

November 18, 2014

(HealthDay)—In metastatic melanoma, nivolumab improves overall and progression-free survival versus dacarbazine, and dabrafenib plus trametinib improves survival versus vemurafenib monotherapy, according to two studies ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.